Predictive accuracy of the complex 30-day model for colon surgical site infections in emergent operations.

Background: Surgical site infections (SSI) following colon surgery continue to pose a significant clinical and financial impact on a healthcare system. The National Healthcare Safety Network (NHSN) utilizes the Complex 30-day SSI model to report the predictive number of infections for a hospital, which is submitted to the Centers for Medicare and Medicaid Services. However, this model does not account for patient acuity.

Adjuvant Chemotherapy for High-Risk Stage II Colon Cancer: A Population-Based Study.

Background: Adjuvant chemotherapy is recommended as an option for patients who have high-risk features. It remains unclear whether all patients with high-risk stage II colon cancer benefit from adjuvant therapy. The primary aim of this study is to evaluate the association between adjuvant chemotherapy and overall survival in patients with high-risk stage II colon cancer.